Most Common Immunological and Autoimmune Disorders
Top Drugs To Watch in HIV (2025)
drugs-launched-in-second-half-2021
Assessment of Key Products that Got F...

Although COVID-19 continued to dominate headlines in 2021, pharmaceutical companies did not cease developin...

pharma-news-for-accutar-bio-thera-nykode-heat-biologics-elusys
Accutar’s Phase I clinical tria...

FDA approves IND application of Accutar for a prostate cancer treatment trial The US Food and Drug Administ...

monoclonal-antibody-therapy
What are Monoclonal Antibodies and Ho...

An antibody is a protein produced by the immune system in response to an infection in the body. Whereas, a&...

progressive-parkinsons-disease-market
Evaluation of Rapidly Evolving Parkinson’s Disease Therapeutic Market

Parkinson's disease is a neurodegenerative disorder that affects predominately dopamine-producing (“dopaminergic”) neurons in a specific area of the brain called substantia nigra. Parkinson's dise...


biosimilar-approvals-and-launches-2021
Insights into some of the Biosimilar Drugs that are approved and launched in 2021

Since the first biosimilar drug was approved in 2006, the EU has led the way in biosimilar regulation. Over the last decade, the EU has authorized the most biosimilars globally, gathering signific...


medtech-news-for-boston-scientific-bd-roche-linus-helioliver
Boston Scientific’s MODULAR CRM System; Restore Medical’s ContraBand clinical trial r...

Boston Scientific initiates trial to evaluate industry's first Modular CRM System  On December 02, 2021, Boston Scientific Corporation started the MODULAR ATP clinical trial to examine the...


biosimilar-market-outlook
Analyzing the Growth of the Biosimilar Market Through Years

The expiration of many biologic drugs patents has sparked biosimilar development and boosted the biosimilar market growth. Biosimilars are alternative versions of innovator biologic drugs. These a...


pharma-news-for-ge-optellum-therapixel-ocugen-blueprint
GE Healthcare-Optellum’s collaboration; Ocugen’s Covid-19 vaccine trial; Blueprint to acqui...

GE Healthcare, Optellum collaborate for AI-based lung cancer diagnosis GE Healthcare has collaborated with Optellum to progress precision diagnosis and lung cancer treatment with artificial int...


pharma-news-for-bluebird-bio-fda-twist-bioscience-sosei-heptares
Bluebird bio may get gene therapy approved in the US; Neurocrine pens $2.6B pact with Sosei Hepta...

Bluebird bio may finally get a gene therapy approved in the US Bluebird bio may get gene therapy approved in the US. The Cambridge, MA biotech declared that the FDA had accepted and given prior...


Editor's Pick
22 Healthcare Trends & Innovations to Watch in 2022 and Beyond

With the advent of new-age healthcare industry trends that are evident as of now, there...

Assessment of Key Products that Got FDA Approval in Second Half (H2) of 2021

Although COVID-19 continued to dominate headlines in 2021, pharmaceutical companies did...

Analyzing the Key Trends Driving the Biosimilar Market Growth

The Biosimilars market is growing at a breakneck pace. The biosimilar market provides a...

CAR-T Cell Therapy aka Miraculous Technology: Mapping the Market, Approved Th...

Chimeric antigen receptor T-cell (CAR T) therapies are shown to have transformative pot...

Myelodysplastic Syndromes (MDS): Key Pharma Players Unveiling Updated Finding...

There has been limited progress in the approval of novel agents in MDS. It has been a l...